Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage

  title={Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage},
  author={Pascale Avery and Sarah Morton and Harriet Tucker and Laura Green and Anne E Weaver and Ross A Davenport},
  journal={Emergency Medicine Journal},
  pages={370 - 378}
Objective In the era of damage control resuscitation of trauma patients with acute major haemorrhage, transfusion practice has evolved to blood component (component therapy) administered in a ratio that closely approximates whole blood (WB). However, there is a paucity of evidence supporting the optimal transfusion strategy in these patients. The primary objective was therefore to establish if there is an improvement in survival at 30 days with the use of WB transfusion compared with blood… Expand
The use of whole blood in traumatic bleeding: a systematic review
The available evidence does not allow to draw definite conclusions on the short-term and long-term efficacy and safety of WB transfusion compared to COMP transfusion, and further well designed research is needed. Expand
Whole blood versus component therapy for haemostatic resuscitation of major bleeding: a protocol for a systematic review and meta-analysis
This study aimed to estimate mortality and complications risk between WB and blood component therapy for haemostatic resuscitation of major bleeding and the Cochrane risk of bias tool for randomised controlled trials and Risk of Bias In Non-randomised Studies - of Interventions (ROBINS-I) for observation studies. Expand
Is fresh, leucodepleted, whole blood transfusion superior to blood component transfusion in pediatric patients undergoing spinal deformity surgeries? A prospective, randomized study analyzing postoperative serological parameters and clinical recovery
FWB transfusion can potentially improve the immediate postoperative outcome in patients undergoing major spinal deformity surgeries by reducing the duration of intensive care unit stay and oxygen dependence and the other potential benefits of this practice, based on the authors' study. Expand
Quality of Platelets in Stored Whole Blood.
Optimization of whole blood storage, with focus on platelet quality, needs to be performed to allow extension of the storage time beyond 15 days to a point where the number of units in inventory and outdating can be balanced. Expand
The Role of α1-Microglobulin (A1M) in Erythropoiesis and Erythrocyte Homeostasis—Therapeutic Opportunities in Hemolytic Conditions
An overview of A1M and its potential therapeutic effect in the context of the following erythropoietic and hemolytic conditions: Diamond-Blackfan anemia (DBA), 5q-minus myelodysplastic syndrome (5q-MDS), blood transfusions, intraventricular hemorrhage (IVH), preeclampsia (PE) and atherosclerosis is provided. Expand
Whole Blood Transfusion: Past, Present, and Future.
  • Elizabeth A Godbey
  • Medicine
  • Clinics in laboratory medicine
  • 2021
Transfusion of whole blood largely was replaced by component therapy in the 1970s and 1980s. The recent military operations in Iraq and Afghanistan returned whole blood to military trauma care.Expand


Increased Mortality in Adult Patients With Trauma Transfused With Blood Components Compared With Whole Blood
Transfusion of whole blood was associated with reduced mortality in adult patients with major trauma and may provide superior survival outcomes in this population of patients, and logistic regression analysis identified 3 independent predictors of mortality: Injury Severity Score, emergency medical system transfer time, and type of blood transfusion. Expand
A Randomized Controlled Pilot Trial of Modified Whole Blood versus Component Therapy in Severely Injured Patients Requiring Large Volume Transfusions
Compared with COMP therapy, WB did not reduce transfusion volumes in severely injured patients predicted to receive massive transfusion, however, in the sensitivity analysis (patients without severe brain injuries), use of mWB significantly reduced transfusions volumes, achieving the prespecified endpoint of this initial pilot study. Expand
Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries.
In patients with trauma with hemorrhagic shock, resuscitation strategies that include W FWB may improve 30-day survival, and may be a result of less anticoagulants and additives with WFWB use in this population. Expand
Massive transfusions for critical bleeding: is everything old new again?
High‐quality evidence to guide transfusion support for critically bleeding patients across the range of bleeding contexts is lacking, including for both trauma and non‐trauma patients, and more data on major haemorrhage support and clinical outcomes are needed. Expand
Early coagulopathy predicts mortality in trauma.
The incidence of coagulation abnormalities, early after trauma, is high and they are independent predictors of mortality even in the presence of other risk factors. Expand
Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients.
There is a high frequency of established coagulopathy in multiple injury upon ER admission and the presence of early traumatic coagULopathy was associated with the amount of intravenous fluids administered pre-clinically, magnitude of injury, and impaired outcome. Expand
The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks.
Higher plasma and platelet ratios early in resuscitation were associated with decreased mortality in patients who received transfusions of at least 3 units of blood products during the first 24 hours after admission, and among survivors at 24 hours, the subsequent risk of death by day 30 was not associated with plasma or Platelet ratios. Expand
Cause and timing of death in massively transfused trauma patients
Characterization of cause of death will allow targeting of surgical and resuscitative conduct to allow extension of the physiologic reserve time, therefore rendering previously nonsurvivable injury potentially survivable. Expand
Acute traumatic coagulopathy.
There is a common and clinically important acute traumatic coagulopathy that is not related to fluid administration that is related to mortality and a coagulation screen is an important early test in severely injured patients. Expand
Damage Control Resuscitation.
Unique aspects of out-of-hospital DCR (point of injury, en-route, and remote DCR) and in-hospital (Medical Treatment Facilities: Role 2b/Forward surgical teams - role 3/ combat support hospitals) are reviewed in this guideline, along with pediatric considerations. Expand